Select Medical Holdings Co. (NYSE:SEM) hit a new 52-week high on Thursday . The stock traded as high as $20.12 and last traded at $19.81, with a volume of 470379 shares changing hands. The stock had previously closed at $19.90.
Several equities analysts have weighed in on SEM shares. Benchmark lifted their price objective on Select Medical from $21.00 to $23.00 and gave the company a “buy” rating in a report on Monday. Credit Suisse Group set a $18.00 price target on Select Medical and gave the company a “hold” rating in a research note on Friday, November 1st. Deutsche Bank started coverage on Select Medical in a research note on Monday, September 16th. They issued a “buy” rating and a $22.00 price target on the stock. Finally, ValuEngine upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $19.40.
The company has a 50 day moving average price of $17.17 and a 200-day moving average price of $15.92. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 4.61. The company has a market cap of $2.64 billion, a P/E ratio of 19.23, a price-to-earnings-growth ratio of 1.26 and a beta of 1.27.
In related news, CEO David S. Chernow sold 74,774 shares of the business’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $18.09, for a total transaction of $1,352,661.66. Following the sale, the chief executive officer now owns 970,260 shares in the company, valued at approximately $17,552,003.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Scott A. Romberger sold 9,344 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $17.26, for a total value of $161,277.44. Following the sale, the senior vice president now owns 146,620 shares in the company, valued at approximately $2,530,661.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 97,138 shares of company stock worth $1,765,660. Corporate insiders own 19.50% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Harel Insurance Investments & Financial Services Ltd. bought a new stake in Select Medical during the 3rd quarter worth $40,000. Coastal Investment Advisors Inc. bought a new stake in Select Medical during the 2nd quarter worth $39,000. Point72 Hong Kong Ltd bought a new stake in Select Medical during the 2nd quarter worth $56,000. Royal Bank of Canada grew its position in Select Medical by 105.6% during the 2nd quarter. Royal Bank of Canada now owns 3,862 shares of the health services provider’s stock worth $62,000 after acquiring an additional 1,984 shares during the last quarter. Finally, Tower Research Capital LLC TRC bought a new stake in Select Medical during the 2nd quarter worth $66,000. Institutional investors and hedge funds own 75.55% of the company’s stock.
Select Medical Company Profile (NYSE:SEM)
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Recommended Story: How the Consumer Price Index (CPI) is calculated?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.